The synoptophore market was valued at USD 240.53 million in 2024 and is projected to reach USD 256.29 million in 2025 and USD 463.31 million by 2034, growing at a CAGR of 6.8% during the 2025–2034 forecast period. The device is widely used in hospitals, eye clinics, and optometric practices for both diagnostic and therapeutic applications. Key players include Haag-Streit Group, Takagi Seiko Co., Ltd., 66 Vision Tech Co., Ltd., Gem Optical Instruments Industries, and Rumax International.

Orthoptic Assessments and Ocular Muscle Imbalances

A synoptophore is used in orthoptic assessments and vision therapy to evaluate and treat ocular muscle imbalances. The diagnostics segment dominated the market in 2024 because synoptophores support comprehensive assessments of ocular muscle imbalances and visual disorders, making them indispensable tools in ophthalmology. The growing demand for non-invasive and precise diagnostic tools, coupled with a rising pediatric and geriatric patient base, contributes to market expansion.

Vision Therapy and Amblyopia Treatment

The therapeutics segment is experiencing significant growth, driven by the increasing adoption of synoptophores in vision therapy. These devices are utilized in the treatment of conditions such as amblyopia, offering non-invasive therapeutic options that enhance patient outcomes. The shift toward personalized medicine and early intervention strategies in ophthalmology has further propelled demand for therapeutic applications. By enabling orthoptic exercises, the device helps stimulate proper eye alignment and muscle coordination.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/synoptophore-market

Clinics Gain Ground in Eye Care

Hospitals hold the largest end-use share because they have the infrastructure to invest in advanced diagnostic and therapeutic tools and serve a large patient base that requires specialized vision care. The clinics segment is experiencing rapid growth, attributed to shorter waiting times, easier accessibility, and lower costs compared with hospitals. The increasing number of orthoptists establishing private practices and the rising prevalence of amblyopia in rural areas further contribute to expansion. Clinics' ability to provide specialized and personalized care also makes them a preferred choice for patients seeking vision therapy.

Imaging Advances and Optical Coherence Tomography

Innovative optical imaging techniques, including optical coherence tomography, angiography, and visible light OCT, allow a thorough evaluation of patients and help clinicians tailor interventions. In April 2024, researchers at the National Institutes of Health applied an AI technique called parallel discriminator generative adversarial network (P-GAN) to adaptive optics-optical coherence tomography, achieving imaging speeds 100 times faster than manual methods and improving image contrast by 3.5-fold.

Industry developments reflect this direction. In March 2025, Haag-Streit introduced the METIS 900, an ophthalmic surgical control center that integrates various surgical technologies into a single platform. In May 2021, Haag-Streit UK launched the Eyestar 900 in the UK, a swept-source OCT-based eye analyzer that enables precise measurement of the entire eye. Haag-Streit Group, established in 1858 and headquartered in Köniz, Switzerland, develops and manufactures medical equipment for ophthalmology, microsurgery, and optics, while Takagi Seiko Corporation, founded in 1955 and based in Takaoka, Toyama Prefecture, Japan, produces medical devices including ophthalmic equipment.

Regional Snapshot

North America held the largest market share in 2024, owing to the increasing prevalence of visual acuity disorders such as amblyopia, a rising inclination toward non-surgical treatment, and the presence of key market players. Europe benefits from a well-established healthcare infrastructure, while Asia Pacific is witnessing significant growth as healthcare standards improve in China, India, and Japan and the large pediatric population drives demand for early diagnosis.

Key Players in the Synoptophore Market

•       66 Vision Tech Co., Ltd.

•       Appasamy Associates

•       Bino Scientific

•       Chongqing Vision Star Optical Co., Ltd.

•       cnshtopview

•       Devine Meditech

•       Gem Optical Instruments Industries

•       Haag-Streit Group

•       Medirer Surgical

•       Nanjing Redsun Optical Co., Ltd.

•       Prkamya Visions

•       Rumax International

•       Shanghai Link Instrument Co., Ltd.

•       Takagi Seiko Co., Ltd.

•       Zabbys

Conclusion

Therapy-led demand and clinic-based care are broadening the role of the synoptophore. With the market projected to reach USD 463.31 million by 2034 at a CAGR of 6.8%, companies that combine reliable orthoptic tools with digital imaging and strong ties to ophthalmic professionals can sustain growth, while limited awareness and the high cost of advanced ophthalmic devices could hinder expansion in low-income regions.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market